CD34 and melanoma: The negative reactivity of tumor cells for other lineage-specific markers, such as cytokeratin AE1/AE3, S100 protein, CD34, and SMA/desmin, allows distinction from poorly differentiated squamous cell carcinoma, melanoma, angiosarcoma, and leiomyosarcoma, respectively.